Real Time Quantitative Assessment of WT1Gene Expression in Patients with Acute Myeloid Leukemia: Impact on Prognosis and Minimal Residual Disease Detection

Mohamed Shokry Mohamed Eid;

Abstract


Accurate assessment of MRD in AML patients after initial chemotherapy is essential to evaluate the efficacy of treatment regimens, to establish early diagnosis of impending relapse and to individualize treatment protocols. Detection of early relapse allow


Other data

Title Real Time Quantitative Assessment of WT1Gene Expression in Patients with Acute Myeloid Leukemia: Impact on Prognosis and Minimal Residual Disease Detection
Other Titles تفاعل البلمرة التسلسلى الزمنى الكمى فى تقييم جين WT1 فى مرضى سرطان الدم النخاعى الحاد: أهميته فى التكهن بمآل المرض واكتشاف بقاياه
Authors Mohamed Shokry Mohamed Eid
Keywords Real Time Quantitative Assessment of WT1Gene Expression in Patients with Acute Myeloid Leukemia: Impact on Prognosis and Minimal Residual Disease Detection
Issue Date 2009
Description 
Accurate assessment of MRD in AML patients after initial chemotherapy is essential to evaluate the efficacy of treatment regimens, to establish early diagnosis of impending relapse and to individualize treatment protocols. Detection of early relapse allow

Recommend this item

Similar Items from Core Recommender Database

Google ScholarTM

Check

views 2 in Shams Scholar


Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.